Advertisement

Topics

Sobi Inc. Company Profile

05:02 EDT 16th October 2018 | BioPortfolio


News Articles [35 Associated News Articles listed on BioPortfolio]

Sobi värvar chef från Pfizer

Fredrik Wetterlundh blir ny HR-chef på Sobi.

EU expands indications for Sobi's Kineret

European regulators expanded treatment indications for Sobi's Kineret, or anakinra, to treat the rare auto-inflammatory disor -More- 

Sobi secures NHS reimbursement for Ravicti

Rare disease group Swedish Orphan Biovitrum (Sobi) says it has gained NHS England reimbursement for Ravicti for long-term management of urea-cycle disorders (UCDs) in adults and children.

EU regulators expand reach of Sobi’s Kineret

European regulators have expanded the scope of Sobi’s Kineret to include the treatment of Still’s disease, a rare, systemic, multi-organ, auto-inflammatory disorder that affects around 25,...

Sobi licenses HLH candidate emapalumab from Novimmune

Novimmune SA granted Swedish Orphan Biovitrum AB (Sobi) exclusive global rights to emapalumab, an interferon gamma antagonist awaiting approval for primary haemophagocytic lymphohitiocytosis (HLH). (S...

Sobi launches Kineret for AOSD, SJIA

Sobi UK and Ireland has announced the launch of Kineret across the country offering a new treatment option for Adult Onset Stills Disease (AOSD) and Systemic-Onset Juvenile Idiopathic Arthritis (SJIA)...

2018 PharmaVOICE 100 – Rami Levin, President, North America, Sobi

In this blog post, we’ll share some highlights about Rami Levin, and see some of the reasons why he was honored in this year’s PharmaVOICE 100. You can also read his full profile here. Sin...

Strong Sobi With New Asset: A Takeover Target For Sanofi?

Swedish rare diseases specialist Sobi has reported strong financials and the acquisition of a rare disease candidate on the verge...   

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [6 Associated Companies listed on BioPortfolio]

Swedish Orphan Biovitrum AB

Sobi is a leading integrated biopharmaceutical company dedicated to bringing innovative therapies and services to improve the lives of rare disease patients and their families. Sobi have a diversi...

Sobi

Sobi is an international specialty healthcare company dedicated to rare diseases. Sobi’s mission is to develop and deliver innovative therapies and services to improve the li...

Sobi Inc.

Biogen and Sobi

Through cutting-edge science and medicine, Biogen discovers, develops and delivers worldwide innovative therapies for people living with serious neurological, autoimmune and rare ...

Bioverativ Inc. & Sobi

Bioverativ (NASDAQ: BIVV) is a global biopharmaceutical company dedicated to transforming the lives of people with hemophilia and other rare blood disorders through world-class re...

More Information about "Sobi Inc." on BioPortfolio

We have published hundreds of Sobi Inc. news stories on BioPortfolio along with dozens of Sobi Inc. Clinical Trials and PubMed Articles about Sobi Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Sobi Inc. Companies in our database. You can also find out about relevant Sobi Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record